Showing results (201-210 of 279) with videos related to

Sort By:
Pageof 28
American Journal of Physiology. Renal Physiology|November 17, 2017
Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot studyHarindra Rajasekeran, Heather N Reich, Michelle A Hladunewich, et al.
The Lancet. Diabetes & Endocrinology|June 20, 2020
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trialDavid Z I Cherney, Claire C J Dekkers, Sean J Barbour, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 12, 2018
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipientsStanley C Jordan, Jua Choi, Olivier Aubert, et al.
Journal of the American Society of Nephrology : JASN|March 1, 2023
Membranous Nephropathy in Syphilis is Associated with Neuron-Derived Neurotrophic FactorSanjeev Sethi, Benjamin Madden, Marta Casal Moura, et al.
Kidney International|March 26, 2017
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working GroupHernán Trimarchi, Jonathan Barratt, Daniel C Cattran, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2004
Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriersDaniel S Warren, Andrea A Zachary, Christopher J Sonnenday, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 31, 2025
Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?Valentina Querin, Leonardo Palazzo, Agnes B Fogo, et al.
Kidney International|February 3, 2012
Pros and cons for C4d as a biomarkerDanielle Cohen, Robert B Colvin, Mohamed R Daha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr miceLihua Bao, Mark Haas, Susan A Boackle, et al.
Journal of the American Society of Nephrology : JASN|July 9, 2015
The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic LesionsSuzanne Wilhelmus, Charles E Alpers, H Terence Cook, et al.
Pageof 28